Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1702177

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1702177

COPD and Asthma Devices Market Report by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Channel (Retail Pharmacies, Hospitals, Online Pharmacies), and Region 2025-2033

PUBLISHED:
PAGES: 141 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2999
PDF & Excel (5 User License)
USD 3999
PDF & Excel (Corporate License)
USD 4999

Add to Cart

The global COPD and asthma devices market size reached USD 47.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 70.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.42% during 2025-2033. The market growth is primarily driven by continual technological advancements in smart inhalers with real-time monitoring capabilities, growing prevalence of respiratory conditions, an enhanced emphasis on personalized treatment options for more accurate drug delivery and increasing demand in emerging markets due to improved healthcare access.

Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness. On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.

COPD and Asthma Devices Market Trends:

The growing global geriatric population, which is highly susceptible to chronic respiratory disorders, represents one of the key factors positively influencing the market. In addition, rising occurrences of respiratory diseases caused due to the rising smoking of cigarettes are increasing the sales of COPD and asthma devices. Apart from this, the increasing expenditure on healthcare and continuous automation in the healthcare industry are contributing to the market growth. The widespread adoption of advanced medical solutions is offering lucrative growth opportunities to manufacturers across the globe. At present, healthcare practitioners and pulmonary diseases specialists are preferring a combination of a drug and a device on account of their fast and effective outcome. Furthermore, the expansion of chemical industries is resulting in the rising environmental pollution level and breathing problems, which, in turn, is driving the market. Additionally, the introduction of portable drug delivery devices is propelling the market growth.

Key Market Segmentation:

Breakup by Product:

  • Inhalers
  • Drug Powdered Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Soft Mist Inhalers
  • Nebulizers
  • Compressor Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

Breakup by Indication:

  • Asthma
  • COPD

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospitals
  • Online Pharmacies

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Adherium Limited, Aristopharma Ltd., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, Cohero Health Inc., Koninklijke Philips N.V., Omron Corporation, Pari Respiratory Equipment Inc., Recipharm AB and Verona Pharma plc.

Key Questions Answered in This Report

  • 1.What was the size of the global COPD and asthma devices market market in 2024?
  • 2.What is the expected growth rate of the global COPD and asthma devices market during 2025-2033?
  • 3.What are the key factors driving the global COPD and asthma devices market?
  • 4.What has been the impact of COVID-19 on the global COPD and asthma devices market?
  • 5.What is the breakup of the global COPD and asthma devices market based on the product?
  • 6.What is the breakup of the global COPD and asthma devices market based on the indication?
  • 7.What is the breakup of the global COPD and asthma devices market based on distribution channel?
  • 8.What are the key regions in the global COPD and asthma devices market?
  • 9.Who are the key players/companies in the global COPD and asthma devices market?
Product Code: SR112025A6126

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global COPD and Asthma Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Drug Powdered Inhalers (DPIs)
      • 6.1.2.2 Metered Dose Inhalers (MDIs)
      • 6.1.2.3 Soft Mist Inhalers
    • 6.1.3 Market Forecast
  • 6.2 Nebulizers
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Compressor Nebulizers
      • 6.2.2.2 Ultrasonic Nebulizers
      • 6.2.2.3 Mesh Nebulizers
    • 6.2.3 Market Forecast

7 Market Breakup by Indication

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 COPD
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Adherium Limited
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Aristopharma Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 AstraZeneca PLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Baxter International Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Boehringer Ingelheim International GmbH
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Cohero Health Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Koninklijke Philips N.V.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Omron Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pari Respiratory Equipment Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Recipharm AB
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Verona Pharma plc
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
Product Code: SR112025A6126

List of Figures

  • Figure 1: Global: COPD and Asthma Devices Market: Major Drivers and Challenges
  • Figure 2: Global: COPD and Asthma Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: COPD and Asthma Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: COPD and Asthma Devices Market: Breakup by Product (in %), 2024
  • Figure 5: Global: COPD and Asthma Devices Market: Breakup by Indication (in %), 2024
  • Figure 6: Global: COPD and Asthma Devices Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: COPD and Asthma Devices Market: Breakup by Region (in %), 2024
  • Figure 8: Global: COPD and Asthma Devices (Inhalers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: COPD and Asthma Devices (Inhalers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: COPD and Asthma Devices (Nebulizers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: COPD and Asthma Devices (Nebulizers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: COPD and Asthma Devices (Asthma) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: COPD and Asthma Devices (Asthma) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: COPD and Asthma Devices (COPD) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: COPD and Asthma Devices (COPD) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: COPD and Asthma Devices (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: COPD and Asthma Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: COPD and Asthma Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: COPD and Asthma Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: COPD and Asthma Devices (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: COPD and Asthma Devices (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: North America: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: North America: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: United States: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: United States: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Canada: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Canada: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Asia-Pacific: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Asia-Pacific: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: China: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: China: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Japan: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Japan: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: India: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: India: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: South Korea: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: South Korea: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Australia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Australia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Indonesia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Indonesia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Europe: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Europe: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Germany: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Germany: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: France: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: France: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: United Kingdom: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: United Kingdom: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Italy: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Italy: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Spain: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Spain: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Russia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Russia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Latin America: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Latin America: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Brazil: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Brazil: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Mexico: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Mexico: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Middle East and Africa: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Middle East and Africa: COPD and Asthma Devices Market: Breakup by Country (in %), 2024
  • Figure 70: Middle East and Africa: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Global: COPD and Asthma Devices Industry: SWOT Analysis
  • Figure 72: Global: COPD and Asthma Devices Industry: Value Chain Analysis
  • Figure 73: Global: COPD and Asthma Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: COPD and Asthma Devices Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: COPD and Asthma Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: COPD and Asthma Devices Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 4: Global: COPD and Asthma Devices Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: COPD and Asthma Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: COPD and Asthma Devices Market: Competitive Structure
  • Table 7: Global: COPD and Asthma Devices Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!